Indivior Executive and Leadership Team

Ryan Preblick, the Chief Financial Officer at Indivior, directs the company's financial strategy and operations. Overseeing all fiscal activities, Preblick ensures robust financial planning, accurate reporting, and effective capital allocation to support Indivior's global mission. This leadership role involves managing budgets, forecasting financial performance, and identifying opportunities for fiscal optimization across the organization. By maintaining strong financial discipline, Ryan Preblick drives the company's pursuit of sustainable growth and profitability in the competitive pharmaceutical market. The Chief Financial Officer's oversight extends to investor relations and treasury functions, ensuring transparency and confidence with stakeholders. Preblick's strategic financial guidance is critical for advancing Indivior's pipeline and market presence.

Scott Reents, the Executive Vice President & Chief Financial Officer at Indivior, manages the company's comprehensive financial framework. Reents oversees global financial planning, analysis, and reporting, ensuring alignment with strategic objectives. This executive role involves driving financial performance, optimizing resource allocation, and maintaining fiscal integrity across all business units. Scott Reents's responsibilities include managing corporate finance, treasury operations, and investor communications, fostering trust and transparency with stakeholders. The Executive Vice President & Chief Financial Officer's strategic financial leadership is essential for supporting Indivior's research and development initiatives and its market expansion efforts. Reents's expertise guides the company's financial health, enabling sustained innovation and operational excellence in the pharmaceutical sector.

Bal Chopra, the Segment Chief Financial Officer & Senior VP, Finance, Operations (US) at Indivior, leads financial strategy and operational oversight for the US segment. Chopra directs financial planning, budgeting, and performance analysis, ensuring fiscal health and strategic alignment within the United States market. This senior leadership position involves managing finance and operations for key business segments, driving efficiency and profitability. Bal Chopra's role is critical in supporting Indivior's mission to treat opioid and alcohol use disorders through effective financial management and operational execution. The Segment Chief Financial Officer & Senior VP, Finance, Operations (US) collaborates closely with divisional leaders to achieve market-specific goals and enhance patient access to vital treatments. Chopra's financial acumen underpins the successful delivery of Indivior's products and services across the US.

Matthew Ruth, the President, Overdose Reversal Sciences Division at Indivior, spearheads the strategic direction and operational execution for overdose reversal therapies. Ruth drives the development, commercialization, and market penetration of critical products aimed at combating the opioid crisis. This leadership role involves overseeing research, clinical development, and market access initiatives for the division's portfolio. Matthew Ruth's focus is on expanding access to life-saving overdose reversal treatments and making a significant impact on public health. The President, Overdose Reversal Sciences Division collaborates with cross-functional teams to ensure the successful delivery of innovative solutions. Ruth's leadership is instrumental in advancing Indivior's commitment to addressing critical unmet medical needs in addiction and related disorders.

Jeffrey Burris, the Chief Legal Officer at Indivior, directs the company's comprehensive legal affairs and corporate governance. Burris oversees all legal operations, ensuring compliance with global regulations and safeguarding Indivior's interests. This critical executive role involves managing litigation, intellectual property, and corporate law matters, providing strategic counsel to the board and senior management. Jeffrey Burris's leadership ensures that Indivior operates with the highest ethical standards and adheres to all applicable legal frameworks. The Chief Legal Officer's expertise is vital for navigating the complex regulatory landscape of the pharmaceutical industry and protecting the company's reputation. Burris's guidance supports Indivior's mission to develop and deliver life-changing treatments for addiction and CNS disorders.